The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients.
D000336:Aerosols; D000403:Airway Resistance / Q000187:drug effects; D000420:Albuterol / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D001249:Asthma / Q000188:drug therapy*; D005243:Feces / Q000032:analysis; D005260:Female; D006801:Humans; D008297:Male; D011175:Positive-Pressure Respiration; D012138:Respiratory Therapy; D013997:Time Factors; D014316:Tritium
D000336:Aerosols; D014316:Tritium; D000420:Albuterol